Loading KURA…
KURA • CIK 0001422143
1. Description of Business Kura Oncology, Inc. is biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer. Our diversified pipeline consists of small molecules designed to target cancer signaling pathways and address significant unmet needs in oncology and hematology. References in these Notes to Financial Statements to “Kura Oncology, Inc.,” “we,” “our” or “us,” refer to Kura Oncology, Inc.
From recent Form 4 filings
Directors who filed Form 4s in the last 2 years (not a full DEF 14A board roster)